Manulife (Manufacturers Life Insurance)
CMPX icon

Manulife (Manufacturers Life Insurance)’s Compass Therapeutics CMPX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$357K Buy
67,466
+27,141
+67% +$157K ﹤0.01% 2288
2025
Q4 		$217K Buy
40,325
+7,164
+22% +$33.1K ﹤0.01% 2494
2025
Q3 		$116K Sell
33,161
-2,392
-7% -$7.55K ﹤0.01% 2745
2025
Q2 		$92.4K Sell
35,553
-3,948
-10% -$8.14K ﹤0.01% 2771
2025
Q1 		$75.1K Sell
39,501
-2,479
-6% -$6.59K ﹤0.01% 2759
2024
Q4 		$60.9K Sell
41,980
-691
-2% -$1.15K ﹤0.01% 2913
2024
Q3 		$78.5K Buy
+42,671
New +$53.2K ﹤0.01% 2920
2024
Q2 		– Sell
-38,386
Closed -$76K – 2981
2024
Q1 		$76K Buy
38,386
+866
+2% +$1.5K ﹤0.01% 2840
2023
Q4 		$58.5K Hold
37,520
– – ﹤0.01% 2909
2023
Q3 		$73.9K Hold
37,520
– – ﹤0.01% 2887
2023
Q2 		$119K Buy
+37,520
New +$118K ﹤0.01% 2785

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Manulife (Manufacturers Life Insurance)'s CMPX Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Compass Therapeutics (CMPX) stake by 67% in Q1 2026, buying an estimated $157K and bringing the position to 67,466 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #2288.

Manulife (Manufacturers Life Insurance) first reported a position in CMPX in Q2 2023 and has held it in 11 quarters since. 201 funds tracked by Wall St. Rank hold CMPX as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 67,466 shares of Compass Therapeutics worth $357K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 27,141 Compass Therapeutics shares in Q1 2026, an estimated $157K.
  • Compass Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2288 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Compass Therapeutics in Q2 2023 and has held it in 11 quarters since.
  • 201 funds tracked by Wall St. Rank held Compass Therapeutics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.